Report Detail

Pharma & Healthcare Global Coccidiosis Treatment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4744409
  • |
  • 28 September, 2026
  • |
  • Global
  • |
  • 125 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Coccidiosis Treatment market size was valued at US$ 150 million in 2025 and is forecast to a readjusted size of US$ 188 million by 2032 with a CAGR of 3.3% during review period.
Coccidiosis is a parasitic disease of a wide variety of animals caused by coccidian protozoa. The disease spreads from one animal to another by contact with infected feces or ingestion of infected tissue. Diarrhea is the primary symptom of Coccidiosis. Coccidia can infect a wide variety of animals, including humans, birds, and livestock, as they are usually species-specific. The coccidia are responsible for major economic losses of the livestock industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Coccidiosis Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Coccidiosis Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Coccidiosis Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Coccidiosis Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Coccidiosis Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Coccidiosis Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Coccidiosis Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Sante Animale, Intas Pharmaceuticals Ltd., Jurox Pty Ltd., Merck Animal Health, Vetoquinol S.A., Virbac S.A., Zoetis, Inc., Novartis Animal Healthcare, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Coccidiosis Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ionophore Drugs
Antibiotic Drugs
Chemical Derivative Drugs
Market segment by Application
Poultry
Fish
Cattle
Major players covered
Bayer Animal Health
Boehringer Ingelheim Vetmedica, Inc.
Ceva Sante Animale
Intas Pharmaceuticals Ltd.
Jurox Pty Ltd.
Merck Animal Health
Vetoquinol S.A.
Virbac S.A.
Zoetis, Inc.
Novartis Animal Healthcare
Smartvet Inc.
Huvepharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Coccidiosis Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Coccidiosis Treatment, with price, sales quantity, revenue, and global market share of Coccidiosis Treatment from 2021 to 2026.
Chapter 3, the Coccidiosis Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Coccidiosis Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Coccidiosis Treatment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Coccidiosis Treatment.
Chapter 14 and 15, to describe Coccidiosis Treatment sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Coccidiosis Treatment Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Ionophore Drugs
    • 1.3.3 Antibiotic Drugs
    • 1.3.4 Chemical Derivative Drugs
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Coccidiosis Treatment Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Poultry
    • 1.4.3 Fish
    • 1.4.4 Cattle
  • 1.5 Global Coccidiosis Treatment Market Size & Forecast
    • 1.5.1 Global Coccidiosis Treatment Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Coccidiosis Treatment Sales Quantity (2021-2032)
    • 1.5.3 Global Coccidiosis Treatment Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bayer Animal Health
    • 2.1.1 Bayer Animal Health Details
    • 2.1.2 Bayer Animal Health Major Business
    • 2.1.3 Bayer Animal Health Coccidiosis Treatment Product and Services
    • 2.1.4 Bayer Animal Health Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bayer Animal Health Recent Developments/Updates
  • 2.2 Boehringer Ingelheim Vetmedica, Inc.
    • 2.2.1 Boehringer Ingelheim Vetmedica, Inc. Details
    • 2.2.2 Boehringer Ingelheim Vetmedica, Inc. Major Business
    • 2.2.3 Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Product and Services
    • 2.2.4 Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Boehringer Ingelheim Vetmedica, Inc. Recent Developments/Updates
  • 2.3 Ceva Sante Animale
    • 2.3.1 Ceva Sante Animale Details
    • 2.3.2 Ceva Sante Animale Major Business
    • 2.3.3 Ceva Sante Animale Coccidiosis Treatment Product and Services
    • 2.3.4 Ceva Sante Animale Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Ceva Sante Animale Recent Developments/Updates
  • 2.4 Intas Pharmaceuticals Ltd.
    • 2.4.1 Intas Pharmaceuticals Ltd. Details
    • 2.4.2 Intas Pharmaceuticals Ltd. Major Business
    • 2.4.3 Intas Pharmaceuticals Ltd. Coccidiosis Treatment Product and Services
    • 2.4.4 Intas Pharmaceuticals Ltd. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Intas Pharmaceuticals Ltd. Recent Developments/Updates
  • 2.5 Jurox Pty Ltd.
    • 2.5.1 Jurox Pty Ltd. Details
    • 2.5.2 Jurox Pty Ltd. Major Business
    • 2.5.3 Jurox Pty Ltd. Coccidiosis Treatment Product and Services
    • 2.5.4 Jurox Pty Ltd. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Jurox Pty Ltd. Recent Developments/Updates
  • 2.6 Merck Animal Health
    • 2.6.1 Merck Animal Health Details
    • 2.6.2 Merck Animal Health Major Business
    • 2.6.3 Merck Animal Health Coccidiosis Treatment Product and Services
    • 2.6.4 Merck Animal Health Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Merck Animal Health Recent Developments/Updates
  • 2.7 Vetoquinol S.A.
    • 2.7.1 Vetoquinol S.A. Details
    • 2.7.2 Vetoquinol S.A. Major Business
    • 2.7.3 Vetoquinol S.A. Coccidiosis Treatment Product and Services
    • 2.7.4 Vetoquinol S.A. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Vetoquinol S.A. Recent Developments/Updates
  • 2.8 Virbac S.A.
    • 2.8.1 Virbac S.A. Details
    • 2.8.2 Virbac S.A. Major Business
    • 2.8.3 Virbac S.A. Coccidiosis Treatment Product and Services
    • 2.8.4 Virbac S.A. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Virbac S.A. Recent Developments/Updates
  • 2.9 Zoetis, Inc.
    • 2.9.1 Zoetis, Inc. Details
    • 2.9.2 Zoetis, Inc. Major Business
    • 2.9.3 Zoetis, Inc. Coccidiosis Treatment Product and Services
    • 2.9.4 Zoetis, Inc. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Zoetis, Inc. Recent Developments/Updates
  • 2.10 Novartis Animal Healthcare
    • 2.10.1 Novartis Animal Healthcare Details
    • 2.10.2 Novartis Animal Healthcare Major Business
    • 2.10.3 Novartis Animal Healthcare Coccidiosis Treatment Product and Services
    • 2.10.4 Novartis Animal Healthcare Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Novartis Animal Healthcare Recent Developments/Updates
  • 2.11 Smartvet Inc.
    • 2.11.1 Smartvet Inc. Details
    • 2.11.2 Smartvet Inc. Major Business
    • 2.11.3 Smartvet Inc. Coccidiosis Treatment Product and Services
    • 2.11.4 Smartvet Inc. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Smartvet Inc. Recent Developments/Updates
  • 2.12 Huvepharma
    • 2.12.1 Huvepharma Details
    • 2.12.2 Huvepharma Major Business
    • 2.12.3 Huvepharma Coccidiosis Treatment Product and Services
    • 2.12.4 Huvepharma Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Huvepharma Recent Developments/Updates

3 Competitive Environment: Coccidiosis Treatment by Manufacturer

  • 3.1 Global Coccidiosis Treatment Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Coccidiosis Treatment Revenue by Manufacturer (2021-2026)
  • 3.3 Global Coccidiosis Treatment Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Coccidiosis Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Coccidiosis Treatment Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Coccidiosis Treatment Manufacturer Market Share in 2025
  • 3.5 Coccidiosis Treatment Market: Overall Company Footprint Analysis
    • 3.5.1 Coccidiosis Treatment Market: Region Footprint
    • 3.5.2 Coccidiosis Treatment Market: Company Product Type Footprint
    • 3.5.3 Coccidiosis Treatment Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Coccidiosis Treatment Market Size by Region
    • 4.1.1 Global Coccidiosis Treatment Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Coccidiosis Treatment Consumption Value by Region (2021-2032)
    • 4.1.3 Global Coccidiosis Treatment Average Price by Region (2021-2032)
  • 4.2 North America Coccidiosis Treatment Consumption Value (2021-2032)
  • 4.3 Europe Coccidiosis Treatment Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Coccidiosis Treatment Consumption Value (2021-2032)
  • 4.5 South America Coccidiosis Treatment Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Coccidiosis Treatment Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Coccidiosis Treatment Sales Quantity by Type (2021-2032)
  • 5.2 Global Coccidiosis Treatment Consumption Value by Type (2021-2032)
  • 5.3 Global Coccidiosis Treatment Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Coccidiosis Treatment Sales Quantity by Application (2021-2032)
  • 6.2 Global Coccidiosis Treatment Consumption Value by Application (2021-2032)
  • 6.3 Global Coccidiosis Treatment Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Coccidiosis Treatment Sales Quantity by Type (2021-2032)
  • 7.2 North America Coccidiosis Treatment Sales Quantity by Application (2021-2032)
  • 7.3 North America Coccidiosis Treatment Market Size by Country
    • 7.3.1 North America Coccidiosis Treatment Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Coccidiosis Treatment Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Coccidiosis Treatment Sales Quantity by Type (2021-2032)
  • 8.2 Europe Coccidiosis Treatment Sales Quantity by Application (2021-2032)
  • 8.3 Europe Coccidiosis Treatment Market Size by Country
    • 8.3.1 Europe Coccidiosis Treatment Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Coccidiosis Treatment Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Coccidiosis Treatment Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Coccidiosis Treatment Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Coccidiosis Treatment Market Size by Region
    • 9.3.1 Asia-Pacific Coccidiosis Treatment Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Coccidiosis Treatment Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Coccidiosis Treatment Sales Quantity by Type (2021-2032)
  • 10.2 South America Coccidiosis Treatment Sales Quantity by Application (2021-2032)
  • 10.3 South America Coccidiosis Treatment Market Size by Country
    • 10.3.1 South America Coccidiosis Treatment Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Coccidiosis Treatment Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Coccidiosis Treatment Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Coccidiosis Treatment Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Coccidiosis Treatment Market Size by Country
    • 11.3.1 Middle East & Africa Coccidiosis Treatment Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Coccidiosis Treatment Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Coccidiosis Treatment Market Drivers
  • 12.2 Coccidiosis Treatment Market Restraints
  • 12.3 Coccidiosis Treatment Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Coccidiosis Treatment and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Coccidiosis Treatment
  • 13.3 Coccidiosis Treatment Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Coccidiosis Treatment Typical Distributors
  • 14.3 Coccidiosis Treatment Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Coccidiosis Treatment. Industry analysis & Market Report on Coccidiosis Treatment is a syndicated market report, published as Global Coccidiosis Treatment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Coccidiosis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report